Abstract

The aim was to examine the interaction of lactoferrin with gram-negative bacteria isolated from ocular adverse responses. Strains representing the species Pseudomonas aeruginosa (six strains), Aeromonas hydrophila, Escherichia coli, Stenotrophomonas maltophilia, and Haemophilus influenza were tested. A modified enzyme-linked immunosorbent assay was used to measure the binding of the strains to native and deglycosylated lactoferrin. The effect on the viability of strains was measured by incubating strains in media containing lactoferrin as the sole carbon and nitrogen source. Siderophore production by strains was measured using an established assay. All the strains except the single strain of E. coli (Ecol8) were capable of binding to lactoferrin. The ocular isolate of H. influenzae showed strong affinity for lactoferrin. The P. aeruginosa strains and the strain of S. maltophilia showed significantly reduced (80%-100% reduction; P<0.05) binding to lactoferrin that had been enzymatically deglycosylated, whereas deglycosylation had no effect on the binding of other strains/species tested. Most strains were able to grow and produce siderophores in the presence of lactoferrin as the sole carbon and nitrogen source. The ability to bind to and grow on lactoferrin can be important for gram-negative pathogens that colonize the ocular environment, because this could allow bacteria to survive and propagate in the presence of tear fluid.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.